arrow_back Back Filing freshness 20-F Q4 FY2025 SEC EDGAR

REGENTIS BIOMATERIALS LTD.

RGNT
$1.40 ▲ +0.02 (+1.45%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
4 Visible periods
5 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

REGENTIS BIOMATERIALS LTD. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC —
FCF / Share —
Trailing P/E —
Price / Book 1.5x
FCF Yield —
Debt / Equity 0.25
info Valuation on last close. End-of-day price, Nov 4, 2026.
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
0
Financial Health
41
Cash Quality ↓
26

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 4 years · 4 quarters